Skip to main content
Log in

Effects of meloxicam on vascular endothelial growth factor and angiopoietin-2 expression in colon carcinoma cell line HT-29

  • Published:
Journal of Huazhong University of Science and Technology Aims and scope Submit manuscript

Summary

To investigate the effect of meloxicam, a selected NSAIDs, on cell growth, expression of VEGF and angiopointin-2 (Ang-2) protein in HT-29 cell line, cultured HT-29 cells were treated with meloxicam of various concentrations for various lengths of time. The proliferation of HT-29 was detected by cell counting kit-8 (CCK-8), the cell cycle was determined by flow cytometer and the levels of VEGF and Ang-2 protein in supernatants were examined by enzyme linked immunosorbent assay (ELISA). The mRNA expressions of VEGF and Ang-2 in cultured HT-29 were determined by real-time quantitative reverse-transcription polymerase chain reaction. Our results showed that treatment of meloxicam of different concentrations and for various lengths of time had a cytotoxicic effect on the cell proliferation of HT-29 cells in a concentration-dependant and time-dependant manner. Cell cycle analysis showed that the cells were mainly blocked in G0/G1 phase. The VEGF and Ang-2 protein levels in supernatants of the culture medium were decreased gradually in a concentration-dependent or time-dependent fashion. The mRNA expression of cox-2, VEGF and Ang-2 showed a gradual and concentration-dependent reduction. It is concluded that meloxicam can reduce the expression of VEGF and Ang-2 at the protein and mRNA level in colon carcinoma cell line.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McColl B K, Baldwin M E, Roufail S et al. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med, 2003,198:863–868

    Article  PubMed  CAS  Google Scholar 

  2. Poltorak Z, Cohen T, Sivan R et al. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem, 1997,272:7151–7158

    Article  PubMed  CAS  Google Scholar 

  3. Saito M, Hamasaki M, Shibuya M. Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF. Cancer Sci 2003, 94990: 782–790

    Article  Google Scholar 

  4. Thurston G, Suri C, Smith K et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science, 1999,286:2511–2514

    Article  PubMed  CAS  Google Scholar 

  5. Thruston G, Rudge J S, Ioffe E et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med, 2000,6:460–463

    Article  CAS  Google Scholar 

  6. Ahmad S A, Liu W, Jung Y D et al. Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma. A possible mechanism for the initiation of angiogenesis. Cancer, 2001; 92:1138–1143

    Article  PubMed  CAS  Google Scholar 

  7. Holash J, Maisonpierre P C, Compton D et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science, 1999,284:1994–1998

    Article  PubMed  CAS  Google Scholar 

  8. Holash J, Wiegand S J, Yancopoulos G D. New model of tumor angiogensis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene,1999,18:5356–5362

    Article  PubMed  CAS  Google Scholar 

  9. Lobov I B, Brooks P C, Lang R A. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA, 2002, 99:11 205–11210

    Article  CAS  Google Scholar 

  10. Smith T J. Cyclooxygenase as the principal targets for the actions of NASAIDs. Rheum Dis Clin Nor Am, 1998,24:501–523

    Article  CAS  Google Scholar 

  11. Sinicrope F A, Gill S. Role of cyclooxygenase-2 in colorectal cancer.Cancer Metastasis Rev, 2004,23:63–75

    Article  PubMed  CAS  Google Scholar 

  12. Oshima M, Dinchuk J E, Karman S L et al. Suppression of intestinal polyposis in Apc delta 716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell, 1996,87:803–809

    Article  PubMed  CAS  Google Scholar 

  13. Seno H, Oshima M, Ishikawa T O et al. Cyclooxygenase-2 and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc (Delta716) mouse intestinal polyps. Cancer Res, 2002,62:506–511

    PubMed  CAS  Google Scholar 

  14. Tomozawa S, Tsuno N H, Sunami E et al. Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis, of colorectal cancer. Br J Cancer, 2000,83:324–328

    Article  PubMed  CAS  Google Scholar 

  15. Williams C S, Tsujii M, Reese J et al. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest, 2000,105:1589–1594

    Article  PubMed  CAS  Google Scholar 

  16. Dempke W, Rie C, Grothey A et al. Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol, 2001,127:411–417

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

ZHANG Ning, female, born in 1979, Doctorial Candidate

This project was supported by a grant from R&D program of Hubei Provincial government (No. 2005AA304B09).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, N., Tao, K. & Huang, T. Effects of meloxicam on vascular endothelial growth factor and angiopoietin-2 expression in colon carcinoma cell line HT-29. J. Huazhong Univ. Sc. Technol. 27, 399–402 (2007). https://doi.org/10.1007/s11596-007-0412-7

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-007-0412-7

Key words

Navigation